Using consideRATE to Evaluate Patient Experience in a Cancer Center: Psychometric and Healthcare Assessments

Competing Interest Statement

Catherine H. Saunders, Glyn Elwyn, and Kathryn Kirkland report copyright but no relevant financial interest in the consideRATE questions, the measure of serious illness care experience assessed in this study. Glyn Elwyn has edited and published books that provide occasional royalties: Shared Decision Making (Oxford University Press) and Groups (Radcliffe Press). Glyn Elwyn's academic interests are focused on shared decision-making and coproduction. In addition to consideRATE, he owns copyright in measures of shared decision making (collaboRATE) and care integration (integRATE), a measure of goal setting (coopeRATE), a measure of clinician willingness to do shared decision making (incorpoRATE), an observer measure of shared decision making (Observer OPTION-5 and Observer OPTION-12). He is the Founder and Director of &think LLC which owns the registered trademark for Option GridsTM patient decision aids. He is an adviser to EBSCO Publishing. All other authors report no conflicts of interest.

Funding Statement

This study was supported by internal funds from the Dartmouth Hitchcock Medical Center Department of Medicine.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Dartmouth Health Institutional Review Board (IRB) approved this study in June 2021 (DH IRB STUDY02000560).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes